MECHANISMS OF HETEROSUBTYPIC IMMUNITY TO LETHAL INFLUENZA-A VIRUS-INFECTION IN FULLY IMMUNOCOMPETENT, T-CELL-DEPLETED, BETA(2)-MICROGLOBULIN-DEFICIENT, AND J-CHAIN-DEFICIENT MICE
Sl. Epstein et al., MECHANISMS OF HETEROSUBTYPIC IMMUNITY TO LETHAL INFLUENZA-A VIRUS-INFECTION IN FULLY IMMUNOCOMPETENT, T-CELL-DEPLETED, BETA(2)-MICROGLOBULIN-DEFICIENT, AND J-CHAIN-DEFICIENT MICE, The Journal of immunology, 158(3), 1997, pp. 1222-1230
Immunity that is cross-protective between different influenza A virus
subtypes (termed heterosubtypic immunity) can be demonstrated readily
in some animals but only rarely in humans. Induction of heterosubtypic
immunity in humans by vaccines would provide public health benefit, p
erhaps offering some protection against pandemics or other new influen
za A strains. Therefore, we studied mechanisms mediating heterosubtypi
c immunity in mice. Immunization with either A/H1N1 or A/H3N2 virus pr
otected mice against mortality following heterosubtypic challenge whil
e providing modest reductions in lung virus titers. No cross-protectio
n was seen with distantly related type B influenza virus. Depletion of
CD4(+) or CD8(+) T cells or both around the time of challenge had no
significant effect on survival, indicating that these cells are not re
quired at the effector stage. beta(2)-microglobulin knockout mice coul
d be protected readily against heterosubtypic challenge, confirming th
at class I-restricted T cells are not required. In beta(2)-microglobul
in -/- mice, depletion of CD4(+) T cells partially abrogated heterosub
typic immunity, showing that they play a role in these mice. Passive t
ransfer of Abs to naive recipients protected against subsequent challe
nge with homologous but not heterosubtypic virus. Because a role for s
ecretory Abs has been suggested, we studied dependence on the I chain,
which is required for polymeric Ig receptor-mediated IgA transport. I
chain knockout mice were readily protected by heterosubtypic immunity
, indicating that polymeric Ig receptor-mediated transport is not requ
ired. Better understanding of heterosubtypic immunity should be valuab
le in analyzing new vaccines, including peptide and DNA vaccines, inte
nded to induce broadly cross-reactive immunity.